FDA gives nod to Bristol Myer’s colorectal cancer therapy
The US Food and Drug Administration has greenlighted Bristol Myers Squibb’s combination therapy to treat metastatic colorectal cancer in patients with a mutated.
Drugs
Health
Pharma
Drugs
Health
Pharma
Eli Lilly’s Zepbound resolves sleep apnea in more than half of trial patients
Tirzepatide, an obesity drug of Eli Lilly and Company, has helped resolve moderate-to-severe obstructive sleep apnea in 52.% of adult patients in two.
Drugs
Health
Pharma
WHO issues medical alert on falsified weight-loss, diabetic drugs
The World Health Organization has issued a medical product alert on falsified semaglutides, an active ingredient in Ozempic, a diabetic drug made by.
Drugs
Health
Pharma
Roche to pay $42 million to Ascidian to make RNA exon editing drugs
Ascidian Therapeutics, a US-based biotechnology company announced a $42 million research pact with Swiss multinational Roche AG for developing gene editing therapies.
Drugs
Health
Pharma
AstraZeneca’s trial breast cancer drug fails to meet primary goals
AstraZeneca’s end-stage experimental trial to treat a certain type of breast cancer failed to meet its dual primary goals, according to a statement.
Drugs
Health
Pharma
Takeda’s trials for epilepsy treatment fail to meet primary seizure goals
Takeda Pharmaceutical Company’s two trials for treating epilepsy did not meet its primary goals of seizure frequency, the Japanese company announced.
Drugs
Health
Pharma
Merck’s vaccine for pneumococcal disease gets FDA’s green light
The US Food and Drug Administration has given the green light to Merck’s vaccine to protect adults against the different types of bacteria.
Drugs
Health
Pharma
FDA gives nod for AstraZeneca’s Imfinzi to treat endometrial cancer
The US Food and Drug Administration has approved AstraZeneca’s combination therapy, Imfinzi, for adult patients with endometrial cancer, according to a company statement.
Drugs
Health
Pharma
US audit finds gaps in FDA’s procedures during infant formula crisis
The US drug regulator, FDA, did not have an organizational structure or assigned responsibilities to handle whistleblower complaints “efficiently and effectively” and took.
Drugs
Health
Pharma
AstraZeneca’s trial drug for mantle cell lymphoma raises survival rate
AstraZeneca’s mantle cell lymphoma combination rug, Calquence, reduced the risk of disease progression or death by up to 27%, according to a company.